Overexpression of the μ-Opioid Receptor in Human Non-Small Cell Lung Cancer Promotes Akt and mTOR Activation, Tumor Growth, and Metastasis

IDENTIFICATION OF CD133+/NESTIN+ PUTATIVE CANCER STEM CELLS IN NON-SMALL CELL LUNG CANCER

(2012) Maria Janikova et al.   BIOMEDICAL PAPERS-OLOMOUC

Morphine-Induced Epidermal Growth Factor Pathway Activation in Non–Small Cell Lung Cancer

(2011) Naomi Fujioka et al.   ANESTHESIA AND ANALGESIA

Transcriptional and Epigenetic Regulation of Opioid Receptor Genes: Present and Future

(2011) Li-Na Wei et al.   Annual Review of Pharmacology and Toxicology

Morphine and tumor growth and metastasis

(2011) Banafsheh Afsharimani et al.   CANCER AND METASTASIS REVIEWS

Low-dose naltrexone suppresses ovarian cancer and exhibits enhanced inhibition in combination with cisplatin

(2011) Renee N Donahue et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

The opioid growth factor (OGF) and low dose naltrexone (LDN) suppress human ovarian cancer progression in mice

(2011) Renee N. Donahue et al.   GYNECOLOGIC ONCOLOGY

Cancer recurrence after surgery: Direct and indirect effects of anesthetic agents*

(2011) Aniket N. Tavare et al.   INTERNATIONAL JOURNAL OF CANCER

Annual Review of Advances in Non-small Cell Lung Cancer Research: A Report for the Year 2010

(2011) Thomas E. Stinchcombe et al.   Journal of Thoracic Oncology

The role of morphine in regulation of cancer cell growth

(2011) Katarzyna Gach et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Pharmacogenomics of the human µ-opioid receptor

(2011) Shinya Kasai et al.   PHARMACOGENOMICS

Bronchioloalveolar Carcinoma

(2011) Douglas Arenberg   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Morphine Use in Cancer Surgery

(2011) Banafsheh Afsharimani et al.   Frontiers in Pharmacology

The Novel Role of the Mu Opioid Receptor in Lung Cancer Progression

(2010) Biji Mathew et al.   ANESTHESIA AND ANALGESIA

Effect of anaesthetic technique and other perioperative factors on cancer recurrence

(2010) G.L. Snyder et al.   BRITISH JOURNAL OF ANAESTHESIA

Prognostic Significance of Nestin Expression in Resected Non-small Cell Lung Cancer

(2010) Shinichiro Ryuge et al.   CHEST

PI3K/Akt/mTOR Pathway Inhibitors in Cancer: A Perspective on Clinical Progress

(2010) P. Wu et al.   CURRENT MEDICINAL CHEMISTRY

Endogenous μ-opioid peptides modulate immune response towards malignant melanoma

(2010) Sandra Boehncke et al.   EXPERIMENTAL DERMATOLOGY

Advances in chemotherapy in advanced non-small-cell lung cancer

(2010) Paolo Maione et al.   EXPERT OPINION ON PHARMACOTHERAPY

Effect of perioperative opioids on cancer recurrence: a hypothesis

(2010) Patrick A Singleton et al.   Future Oncology

Expression of nestin in lymph node metastasis and lymphangiogenesis in non-small cell lung cancer patients

(2010) Zhenguang Chen et al.   HUMAN PATHOLOGY

Dynamics of human cancer cell lines monitored by electrical and acoustic fluctuation analysis

(2010) Marco Tarantola et al.   Integrative Biology

TGF-² Signaling Pathway in Lung Adenocarcinoma Invasion

(2010) Rebecca L. Toonkel et al.   Journal of Thoracic Oncology

Nestin expression in human tumors and tumor cell lines.

(2010) O. Krupkova_Jr et al.   NEOPLASMA

The effect on radioresistance of manganese superoxide dismutase in nasopharyngeal carcinoma

(2010) Zhao   ONCOLOGY REPORTS

Temsirolimus in patients with advanced renal cell carcinoma: an overview

(2009) Shailender Bhatia et al.   ADVANCES IN THERAPY

Long-Term Survival After Colon Cancer Surgery: A Variation Associated with Choice of Anesthesia

(2009) Rose Christopherson et al.   ANESTHESIA AND ANALGESIA

Anesthetic Technique for Radical Prostatectomy Surgery Affects Cancer Recurrence

(2009) Barbara Biki et al.   ANESTHESIOLOGY

PI3K and mTOR inhibitors—a new generation of targeted anticancer agents

(2009) Saskia Brachmann et al.   CURRENT OPINION IN CELL BIOLOGY

The stimulative effects of endogenous opioids on endothelial cell proliferation, migration and angiogenesis in vitro

(2009) Xu Dai et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9

(2009) Jing-song Chen et al.   HEPATOLOGY RESEARCH

Revisiting the ALA/N (α-Lipoic Acid/Low-Dose Naltrexone) Protocol for People With Metastatic and Nonmetastatic Pancreatic Cancer: A Report of 3 New Cases

(2009) Burton M. Berkson et al.   INTEGRATIVE CANCER THERAPIES

Primary Non–Small Cell Lung Cancer: Review of Frequency, Location, and Time of Recurrence after Radiofrequency Ablation

(2009) Michael D. Beland et al.   RADIOLOGY

Lung cancer: Progress in diagnosis, staging and therapy

(2009) Stephen G. SPIRO et al.   RESPIROLOGY

The Other Side of the Opioid Story: Modulation of Cell Growth and Survival Signaling

(2008) Yulong Chen et al.   CURRENT MEDICINAL CHEMISTRY

Placenta growth factor, PLGF, influences the motility of lung cancer cells, the role of Rho associated kinase, Rock1

(2008) Jinfeng Chen et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Isolation and characterization of new exon 11-associated N-terminal splice variants of the human mu opioid receptor gene

(2008) Jin Xu et al.   JOURNAL OF NEUROCHEMISTRY

EGF Transregulates Opioid Receptors through EGFR-mediated GRK2 Phosphorylation and Activation

(2008) Yuejun Chen et al.   MOLECULAR BIOLOGY OF THE CELL

Synergistic effects of methylnaltrexone with 5-fluorouracil and bevacizumab on inhibition of vascular endothelial growth factor–induced angiogenesis

(2008) Patrick A. Singleton et al.   MOLECULAR CANCER THERAPEUTICS

Mammalian target of rapamycin inhibition as a therapeutic strategy in the management of urologic malignancies: Figure 1.

(2008) Jorge A. Garcia et al.   MOLECULAR CANCER THERAPEUTICS

Mechanisms of Disease: survival benefit of temsirolimus validates a role for mTOR in the management of advanced RCC

(2008) Robert A Figlin   Nature clinical practice. Oncology